$CJMB Balance Sheet | Understand Stock

$CJMB

$0.49 -$0.08 (14.63%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024
Assets
Current Assets:
Cash and cash equivalents
Accounts receivable, net of allowance for credit losses of $23,925 and $61,675, respectively
Inventory
Related party loans
Tax refund receivable
Prepaid insurance
Deferred offering costs
Other current assets
Total current assets
Right of use assets – operating lease
Advances to affiliate
Property and equipment, net of accumulated depreciation of $834,881 and $760,655, respectively
Security deposit
Total assets
Liabilities and Stockholders’ Equity
Current Liabilities:
Accounts payable and accrued expenses
Accounts payable
Accrued expenses
Corporate taxes payable
Related party loans
Deferred revenue
Deferred tax liability
Note payable
Right of use liabilities – operating lease
Total current liabilities
Deferred revenue, net of current portion
Derivative liability
Deferred tax liabilities
Total long-term liabilities
Total liabilities
Stockholders’ Equity
Common stock - authorized 190,000,000 shares, par value $0.001 par value, 5,664,868 issued and outstanding as of June 30, 2026 and 4,858,663 December 31, 2025
Additional Paid in Capital
Accumulated Deficit
Total Stockholders’ Equity
Total Liabilities and Stockholders’ Equity

Comments